Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHSPX:US

36.22 USD 0.23 0.64%

As of 09:29:30 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSPX)

Year To Date: +23.20% 3-Month: +13.36% 3-Year: +17.10% 52-Week Range: 25.84 - 36.54
1-Month: +3.75% 1-Year: +37.70% 5-Year: +12.23% Beta vs SPX: 0.85

Mutual Fund Chart for SHSPX

No chart data available.
  • SHSPX:US 36.22
  • 1M
  • 1Y
Interactive SHSPX Chart

Previous Close

Fund Profile & Information for SHSPX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 10-16-2000 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHSPX

NAV (on 2013-05-17) 36.22
Assets (M) (on 2013-05-17) 2,652.60
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment 50.00

Dividends for SHSPX

No dividends reported

Fees & Expenses for SHSPX

Front Load 0.00
Back Load 4.50
Current Mgmt Fee 0.73
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.07

Top Fund Holdings for SHSPX

Filing Date: 12/31/2012
Name Position Value % of Total
Pfizer Inc 4,340,140 108,850,711 5.513%
Eli Lilly & Co 1,603,600 79,089,552 4.005%
Johnson & Johnson 1,043,900 73,177,390 3.706%
Roche Holding AG 353,600 71,491,268 3.621%
Sanofi 735,200 69,719,311 3.531%
Celgene Corp 748,152 58,894,525 2.983%
Novartis AG 833,900 52,680,203 2.668%
Express Scripts Holding Co 920,447 49,704,138 2.517%
Alexion Pharmaceuticals Inc 495,101 46,445,425 2.352%
Biogen Idec Inc 309,400 45,379,698 2.298%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil